Comparison of In-Hospital Mortality and Complications of Primary Percutaneous Coronary Intervention in Diabetics and Non-diabetic patients at a large Tertiary care hospital.
Abstract
Abstract Views: 0
Abstract
Background: Ischemic heart disease is the leading cause of death in Pakistan. We aimed to compare in-hospital mortality and complications of Primary Percutaneous Coronary Intervention (PCI) in diabetics and non-diabetic patients who had a diagnosis of ST-elevation myocardial infarction.
Methods: This cross-sectional study was conducted at a tertiary care hospital and involved 560 patients. The patients were divided into diabetic and non-diabetic groups. Demographics, characteristics, risk factors, coronary vessel details, and post-PCI complications were compared between the groups.
Results: The mean age of 560 patients was 52.17±11.5, of which males comprise 88.6%. Premature coronary disease and hypertension were more prominent in diabetics, while the percentage of smokers was higher in the non-diabetic group. No statistical significance was noted in the severity of stenosis or culprit vessels between groups. The incidence of post-PCI complications was insignificant among both groups. TIMI 0 and 3 are more prevalent in the non-diabetics group, while TIMI 1 and 2 were common in diabetics.
Conclusion: In this single-center study, There was no significant difference noted in-hospital mortality and other post-PCI complications between both groups. Further multicenter, prospective, and larger sample-size studies are needed.
Downloads
References
Samad Z, Hanif B. Cardiovascular diseases in Pakistan: imagining a postpandemic, postconflict future. Circulation. 2023;147(17):1261–1263. https://doi.org/10.1161/CIRCULATIONAHA.122.059122
Zubair F, Nawaz SK, Nawaz A, Nangyal H, Amjad N, Khan MS. Prevalence of cardiovascular diseases in Punjab, Pakistan: a cross-sectional study. J Pub Health. 2018;26:523–529. https://doi.org/10.1007/s10389-018-0898-4
Liaquat A, Javed Q. Current trends of cardiovascular risk determinants in Pakistan. Cureus. 2018;10(10):e3409. https://doi.org/10.7759/cureus.3409
Marcusohn E, Benaim AR, Ronen S, Kerner A, Beyar R, Almog R. Door to balloon time in primary percutaneous coronary intervention in ST elevation myocardial infarction: every minute counts. Coron Art Dis. 2022;33(5):341–348. https://doi.org/10.1097/MCA.0000000000001145
Glovaci D, Fan W, Wong ND. Epidemiology of diabetes mellitus and cardiovascular disease. Curr Cardiol Rep. 2019;21:e21. https://doi.org/10.1007/s11886-019-1107-y
Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H, WHO Multinational Study Group. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes. Diabetologia. 2001;44:eS14. https://doi.org/10.1007/PL00002934
Nairooz R, Sardar P, Amin H, Chatterjee S, Helmy T, Naidu SS. Short‐and long‐term outcomes in diabetes patients undergoing percutaneous coronary intervention with bivalirudin compared with heparin and glycoprotein IIb/III A inhibitors: a meta‐analysis of randomized trials. Catheter Cardiovas Interven. 2015;86(3):364–375. https://doi.org/10.1002/ccd.25952
Paneni F, Costantino S, Cosentino F. Insulin resistance, diabetes, and cardiovascular risk. Curr Atheros Rep. 2014;16:e419. https://doi.org/10.1007/s11883-014-0419-z
Adeva-Andany MM, Martínez-Rodríguez J, González-Lucán M, Fernández-Fernández C, Castro-Quintela E. Insulin resistance is a cardiovascular risk factor in humans. Diab Metabol Synd: Clinic Res Rev. 2019;13(2):1449–1455. https://doi.org/10.1016/j.dsx.2019.02.023
Berry C, Tardif JC, Bourassa MG. Coronary heart disease in patients with diabetes: part II: recent advances in coronary revascularization. J Amer College Cardiol. 2007;49(6):643–656.
Chichareon P, Modolo R, Kogame N, et al. Association of diabetes with outcomes in patients undergoing contemporary percutaneous coronary intervention: pre-specified subgroup analysis from the randomized GLOBAL LEADERS study. Atherosclerosis. 2020;295:45–53. https://doi.org/10.1016/j.atherosclerosis.2020.01.002
Lee TT, Feinberg L, Baim DS, et al. Effect of diabetes mellitus on five-year clinical outcomes after single-vessel coronary stenting (a pooled analysis of coronary stent clinical trials). Am J Cardiol. 2006;98(6):718–721. https://doi.org/10.1016/j.amjcard.2006.03.059
Milojevic M, Serruys PW, Sabik JF, et al. Bypass surgery or stenting for left main coronary artery disease in patients with diabetes. J Am College Cardiol. 2019;73(13):1616–1628.
Norhammar A, Lagerqvist B, Saleh N. Long-term mortality after PCI in patients with diabetes mellitus: results from the Swedish Coronary Angiography and Angioplasty Registry. Eurointervention. 2010;5(8):891–897.
Chichareon P, Modolo R, Kogame N, et al. Association of diabetes with outcomes in patients undergoing contemporary percutaneous coronary intervention: pre-specified subgroup analysis from the randomized GLOBAL LEADERS study. Atherosclerosis. 2020;295:45–53. https://doi.org/10.1016/j.atherosclerosis.2020.01.002
Copyright (c) 2025 Hafiz Mudabbar Mahboob, Samra Yasmin, Hafiz Muhammad Sohaib Hayat, Sarmad Zahoor, Mishel Zainab, Hamza Naeem
This work is licensed under a Creative Commons Attribution 4.0 International License.
BSR follows an open-access publishing policy and full text of all published articles is available free, immediately upon publication of an issue. The journal’s contents are published and distributed under the terms of the Creative Commons Attribution 4.0 International (CC-BY 4.0) license. Thus, the work submitted to the journal implies that it is original, unpublished work of the authors (neither published previously nor accepted/under consideration for publication elsewhere). On acceptance of a manuscript for publication, a corresponding author on the behalf of all co-authors of the manuscript will sign and submit a completed the Copyright and Author Consent Form.
